Middle East & Africa Plasmid Dna Manufacturing Market Size & Outlook
Middle East & Africa plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
MEA plasmid dna manufacturing market highlights
- The MEA plasmid dna manufacturing market generated a revenue of USD 68.6 million in 2024.
- The market is expected to grow at a CAGR of 16% from 2025 to 2030.
- In terms of segment, gmp grade was the largest revenue generating grade in 2024.
- GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 68.6 million |
| Market revenue in 2030 | USD 164.0 million |
| Growth rate | 16% (CAGR from 2025 to 2030) |
| Largest segment | Gmp grade |
| Fastest growing segment | GMP Grade |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | R&D Grade, GMP Grade |
| Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.2% of the global plasmid dna manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,484.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Manufacturing Market Scope
Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 98.69% in 2024. Horizon Databook has segmented the Middle East & Africa plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
The incidence of cancer is expected to significantly increase in the Middle East in the coming years. Presence of unmet medical needs has fueled the demand for robust cancer management, which, in turn, increases the demand for viral vectors and plasmid DNAs.
Furthermore, the high safety, specificity, and efficacy of gene therapies over other treatment methodologies and increasing awareness about gene therapy among people are anticipated to increase the demand for viral vectors for producing therapeutic products over the forecast period.
In February 2020, two sisters from Abu Dhabi received the country’s first gene therapy treatment for vision loss caused due to irreversible blindness at Cleveland Clinic, UAE. This improved the vision of both sisters after treatment with gene therapy.
Reasons to subscribe to Middle East & Africa plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa plasmid dna manufacturing market databook
-
Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa plasmid dna manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA plasmid dna manufacturing market size, by country, 2018-2030 (US$M)
Middle East & Africa Plasmid DNA Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
